CGMs, like the Libre systems, can help you manage your glucose levels*†1,‡2—even if you’re not taking insulin.
With the Libre 3 system, Penny can see what food causes her glucose to spike in real time.
— Penny, manages T2D with oral medication and the FreeStyle Libre 3 system
T2D = type 2 diabetes
With CGMs like the Libre systems, which provide continuous glucose readings, you can see how your GLP-1 therapy is helping in real time.
— Dawn manages T2D with GLP-1 therapy and the FreeStyle Libre 3 Plus sensor
GLP-1 = glucagon-like peptide-1; T2D = type 2 diabetes
An automated insulin delivery (AID) system provides continuous flow of insulin using data from your CGM sensor.
As a full-time mountain guide, Sarah relies on her pump paired with her Libre 3 system to keep her glucose levels steady.
— Sarah, manages T1D with an insulin pump and the FreeStyle Libre 3 system
T1D = type 1 diabetes
Johnny’s parents monitor his glucose levels on their smartphones¶, giving him more freedom to be a kid!
— Johnny’s mother; Johnny manages T1D with daily insulin injections and the FreeStyle Libre 3 sensor
T1D = type 1 diabetes
If you have T1D or T2D, the Libre systems can help you stay on top of your glucose levels. You’ll see your numbers in real time, so you can make insulin adjustments when needed to feel your best.
Chelsee lives an active lifestyle and doesn’t let fingerpricking§ get in the way of the activities she enjoys, such as swimming‡‡ and playing soccer.
— Chelsee, manages T1D with insulin and the Libre 3 system
T1D = type 1 diabetes; T2D = type 2 diabetes
CGMs, like the Libre systems, can help you manage your glucose levels*†1,‡2—even if you’re not taking insulin.
With the Libre 3 system, Penny can see what food causes her glucose to spike in real time.
— Penny, manages T2D with oral medication and the FreeStyle Libre 3 system
T2D = type 2 diabetes
With CGMs like the Libre systems, which provide continuous glucose readings, you can see how your GLP-1 therapy is helping in real time.
— Dawn manages T2D with GLP-1 therapy and the FreeStyle Libre 3 Plus sensor
GLP-1 = glucagon-like peptide-1; T2D = type 2 diabetes
An automated insulin delivery (AID) system provides continuous flow of insulin using data from your CGM sensor.
As a full-time mountain guide, Sarah relies on her pump paired with her Libre 3 system to keep her glucose levels steady.
— Sarah, manages T1D with an insulin pump and the FreeStyle Libre 3 system
T1D = type 1 diabetes
Johnny’s parents monitor his glucose levels on their smartphones¶, giving him more freedom to be a kid!
— Johnny’s mother; Johnny manages T1D with daily insulin injections and the FreeStyle Libre 3 sensor
T1D = type 1 diabetes
If you have T1D or T2D, the Libre systems can help you stay on top of your glucose levels. You’ll see your numbers in real time, so you can make insulin adjustments when needed to feel your best.
Chelsee lives an active lifestyle and doesn’t let fingerpricking§ get in the way of the activities she enjoys, such as swimming‡‡ and playing soccer.
— Chelsee, manages T1D with insulin and the Libre 3 system
T1D = type 1 diabetes; T2D = type 2 diabetes
Everyone’s journey with diabetes is different, and Libre systems put you in control of yours. With Libre CGM systems, you can see how food, exercise, and everyday life impact your glucose—24/7||. And best of all, no fingersticks§ to slow you down!
Request your prescription, and you’re on your way to better glucose management‡9.
Why wait any longer? Talk to your healthcare provider about Libre CGM systems. This simple discussion guide can help you get the conversation started.
The views expressed should not be used for medical diagnosis or treatment or as a substitute for professional medical advice. Individual symptoms, situations and circumstances may vary.
FreeStyle Libre 3 system is cleared to be used by children 4 years and older with Libre 3 sensor and 2 years and older with Libre 3 Plus sensor.
FreeStyle Libre 2 system is cleared to be used by children 4 years and older with Libre 2 sensor and 2 years and older with Libre 2 Plus sensor.
Medicare and other payor criteria may apply.
* Study was performed with the US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 3 and FreeStyle Libre 2 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.
† Retrospective observational study with average baseline A1C 10.1% ± 1.7%.
‡ Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 3 and FreeStyle Libre 2 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.
§ Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first twelve hours.
|| 60-minute warm-up required when starting the sensor.
¶ The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.
# Among patient-applied sensors.
** The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.
†† Alarm notifications will only be received when alarms settings are enabled and turned on and sensor is within 20 feet (FreeStyle Libre 2) or 33 feet (FreeStyle Libre 3) unobstructed of the reading device.
‡‡ Sensor is water-resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes.
References: 1. Wright, Eugene E Jr, et al. “Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy.” Diabetes Spectrum 34, no. 2 (2021): 184–189. ds200069. https://doi.org/10.2337/ds20-0069. 2. Aronson, Ronnie, et al. “IMpact of Flash Glucose Monitoring in pEople With Type 2 Diabetes Inadequately Controlled With Non-Insulin Antihyperglycaemic ThErapy (IMMEDIATE): A Randomized Controlled Trial.” Diabetes, Obesity and Metabolism 25, no. 4 (2023): 1024–1031. https://doi.org/10.1111/dom.14949. 3. FreeStyle Libre 3 and FreeStyle Libre 2 User Manuals. 4. Data on file. Abbott Diabetes Care, Inc. 5. Alva, Shridhara, et al. “Accuracy of a 15-day Factory-Calibrated Continuous Glucose Monitoring System with Improved Sensor Design.” Journal of Diabetes Science and Technology (2025): 19322968251329364. https://doi.org/10.1177/19322968251329364. 6. Fokkert, Marion, et al. “Improved Well-Being and Decreased Disease Burden After 1-Year Use of Flash Glucose Monitoring (FLARE-NL4).” BMJ Open Diabetes Research and Care 7, no. 1 (2019): e000809. https://doi.org/10.1136/bmjdrc-2019-000809. 7. Stress and Diabetes. Diabetes UK. British Diabetes Association. Accessed September 9, 2026. https://www.diabetes.org.uk/living-with-diabetes/emotional-wellbeing/stress. 8. Deepanjali, Vedantam, et al. “Stress-Induced Hyperglycemia: Consequences and Management.” Cureus 14, no. 7 (2022). Accessed September 9, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC9360912/. 9. Evans, Mark, Zoë Welsh, and Alexander Seibold. “Reductions in HbA1c With Flash Glucose Monitoring Are Sustained for up to 24 Months: A Meta-analysis of 75 Real-world Observational Studies.” Diabetes Therapy 13, no. 6 (2022): 1175–1185. https://doi.org/10.1007/s13300-022-01253-9.
The "Yes" link below will take you out of the Abbott Laboratories family of websites. Links which take you out of Abbott Laboratories worldwide web sites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the contents of any such site or any further links from such site. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott Laboratories.
Do you wish to leave this site?
